Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in ADCT — ADC Therapeutics SA

CIK 916542 Boston, MA
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$385,468
-$1,298,739 QoQ
Shares Held
360,251
-19.8% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 113 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. ADCT ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 318,320 $172,475,325
2 NBIX
Neurocrine Biosciences Inc
 441,371 $74,388,668
3 KNSA
Kiniksa Pharmaceuticals International, plc
 679,083 $43,427,357
4 RDY
Dr Reddys Laboratories Ltd
 2,260,243 $32,750,921
5 INDV
Indivior Pharmaceuticals, Inc.
 733,974 $30,114,953
6 AMRX
Amneal Pharmaceuticals, Inc.
 1,650,255 $28,565,914
7 BHC
Bausch Health Companies Inc.
 5,482,986 $27,031,120
8 ZTS
Zoetis Inc.
 364,442 $26,188,802

All Filings in ADCT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $385,468 360,251
2026-03-31 $1,684,207 449,122
2025-12-31 $1,867,246 528,965
2025-09-30 $910,000 227,500
2024-06-30 $51,994 16,454
2023-12-31 $240,464 144,858
2023-09-30 $139,975 156,048
2023-06-30 $47,003 21,862
2022-12-31 $10,348 2,695